Skip to main content
. 2014 Dec;38(6):270–275. doi: 10.1192/pb.bp.113.046474

Table 2.

Clinical measures pre- and post-treatment for each subgroup with two or more sessions

Mean (s.d.)
ESL
(n = 43)
N-ESL
(n = 296)
Physical
disability
(n = 56)
No
disability
(n = 257)
Substance/
alcohol misuse
(n = 109)
No
misuse
(n = 232)
Total
(n = 366)
PHQ-9
    Pre 17.1 (6.5) 17.2 (6.1) 18.9 (5.3) 16.5 (6.2) 17.9 (5.7) 16.8 (6.4) 17 (6.3)
    Post 10.2 (8.3) 12.2 (8) 13.1 (8) 11.3 (7.8) 13.2 (8) 11.3 (7.9) 12 (8)
    Effect size 0.83 0.63 0.73 0.54 0.59 0.7 0.63








GAD-7
    Pre 14.3 (5.3) 14.9 (5.2) 16.1 (4.7) 14.2 (5.2) 15.3 (5) 14.5 (5.2) 14.6 (5.3)
    Post 8.8 (7) 10.5 (6.7) 11.8 (6.6) 9.6 (6.7) 11.4 (6.8) 9.7 (6.7) 10.3 (6.8)
    Effect size 0.79 0.66 0.65 0.69 0.57 0.72 0.63








WSAS
    Pre 21.3 (11.7) 21.6 (10.3) 26.5 (9.2) 20.3 (10.3) 22.4 (10.3) 21.3 (10.6) 21.3 (10.6)
    Post 12.5 (11.9) 17 (12) 21.4 (12.7) 14.9 (11.5) 17.1 (11.8) 16.2 (12.2) 16.5 (12)
    Effect size 0.74 0.38 0.4 0.47 0.45 0.42 0.4

ESL, early service leavers; GAD-7, Generalised Anxiety Disorder scale; N-ESL, non-early service leavers; PHQ-9, Patient Health Questionnaire; WSAS, Work and Social Adjustment Scale.